Impact of Hydroxychloroquine on Mortality in Hospitalized Patients with COVID-19: Systematic Review and Meta-Analysis
Coronavirus disease 2019 (COVID-19) caused by Severe Acute Respiratory Syndrome Coronavirus 2 (SARS-CoV-2) has caused significant health and economic havoc around the globe. One of the early agents targeted for repurposing to treat and prevent COVID-19 was hydroxychloroquine (HCQ). In this systemati...
Main Authors: | Thomas S. Hong, Jimmy Gonzalez, Ronald G. Nahass, Luigi Brunetti |
---|---|
Format: | Article |
Language: | English |
Published: |
MDPI AG
2020-11-01
|
Series: | Pharmacy |
Subjects: | |
Online Access: | https://www.mdpi.com/2226-4787/8/4/208 |
Similar Items
-
Use of chloroquine and hydroxychloroquine in COVID-19 patients: A dilemma
by: Archana Bhatia, et al.
Published: (2022-01-01) -
The role of hydroxychloroquine in COVID-19: Where do we stand?
by: Ranjit Mohan Anjana, et al.
Published: (2020-01-01) -
Hydroxychloroquine Inhibits Cardiac Conduction in Aged Patients with Nonmalaria Diseases
by: Yanting Yu, et al.
Published: (2021-04-01) -
Use of hydroxychloroquine and chloroquine in COVID-19: How good is the quality of randomized controlled trials?
by: Faizan Mazhar, et al.
Published: (2020-12-01) -
A systematic review on the therapeutic relevance of hydroxychloroquine/chloroquine in the management of COVID-19
by: Gerard Mccabe, et al.
Published: (2021-01-01)